Literature DB >> 12936986

Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

M Quinteros1, M Radice, N Gardella, M M Rodriguez, N Costa, D Korbenfeld, E Couto, G Gutkind.   

Abstract

Resistance to extended-spectrum cephalosporins is often associated with plasmid encoded extended spectrum beta-lactamases (ESBL). In order to evaluate the prevalence and diversity of ESBLs in enterobacteria in our city, a 1-month-period survey was carried out from April to May 2000. Extended-spectrum-cephalosporin-resistant strains, isolated from inpatient clinical specimens other than stools, were collected among 17 participating hospitals. From a total of 427 enterobacterial strains that were collected during this period, 39 were extended-spectrum cephalosporin resistant. The National Committee for Clinical Laboratory Standards' Screening and Confirmatory Tests for ESBL production were performed using cefotaxime and ceftazidime; cefepime and cefepime-clavulanic acid-containing disks were included. beta-Lactamases were characterized by isoelectric focusing and PCR amplification using specific primers. Three different ESBLs were detected: SHV-related (4 isolates), PER-2-type (9 isolates), and CTX-M-2-related (26 isolates). Sequencing of the corresponding genes confirmed CTX-M-2 in 19 of 21 and CTX-M-31 (an allelic variant) in the remaining 2 of 21. CTX-M-2 (or its variant) was detected in all Escherichia coli, Enterobacter aerogenes, Serratia marcescens, Proteus mirabilis, and Providencia stuartii strains, while PER-2 was detected in Enterobacter cloacae, E. aerogenes, and Klebsiella pneumoniae; SHV-related ESBL were found only in K. pneumoniae. These results clearly show that CTX-M-2 is the most prevalent ESBL produced by enterobacterial species isolated from public hospitals in Buenos Aires.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12936986      PMCID: PMC182650          DOI: 10.1128/AAC.47.9.2864-2867.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Early dissemination of CTX-M-derived enzymes in South America.

Authors:  Marcela Radice; Pablo Power; Jose Di Conza; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina.

Authors:  Alejandro Petroni; Alejandra Corso; Roberto Melano; María Luisa Cacace; Ana María Bru; Alicia Rossi; Marcelo Galas
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 3.  Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.

Authors:  E Collatz; R Labia; L Gutmann
Journal:  Mol Microbiol       Date:  1990-10       Impact factor: 3.501

4.  A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.

Authors:  A Bauernfeind; J M Casellas; M Goldberg; M Holley; R Jungwirth; P Mangold; T Röhnisch; S Schweighart; R Wilhelm
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

5.  Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find.

Authors:  P E Coudron; E S Moland; C C Sanders
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

6.  Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group.

Authors:  C Bantar; A Famiglietti; M Goldberg
Journal:  Int J Infect Dis       Date:  2000       Impact factor: 3.623

7.  Cefotaxime-hydrolysing beta lactamases in Morganella morganii.

Authors:  P Power; M Radice; C Barberis; C de Mier; M Mollerach; M Maltagliatti; C Vay; A Famiglietti; G Gutkind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

8.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

9.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

10.  Third-generation cephalosporin resistance in Shigella sonnei, Argentina.

Authors:  M Radice; C Gonzéález; P Power; M C Vidal; G Gutkind
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

View more
  52 in total

1.  High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.

Authors:  Hyunjoo Pai; Jung Yun Hong; Jeong-Hum Byeon; Yun-Kyung Kim; Hoan-Jong Lee
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Authors:  Mei-Fen Tsou; Wen-Liang Yu; Siu Wan Hung; Chizh-Ju Chi; Ssu Ching Chen; Lii-Tzu Wu
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase.

Authors:  Kerry J Welsh; Miriam Barlow; Fred C Tenover; James W Biddle; J Kamile Rasheed; Leigh Ann Clark; John E McGowan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay.

Authors:  Rafael Vignoli; Gustavo Varela; María Inés Mota; Nicolas F Cordeiro; Pablo Power; Elizabet Ingold; Pilar Gadea; Alfredo Sirok; Felipe Schelotto; Juan A Ayala; Gabriel Gutkind
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate.

Authors:  Mariagrazia Perilli; Claudia Mugnaioli; Francesco Luzzaro; Marianna Fiore; Stefania Stefani; Gian Maria Rossolini; Gianfranco Amicosante
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Transcriptional analysis of the bla(CTX-M-2) gene in Salmonella enterica serovar Infantis.

Authors:  José A Di Conza; Gabriel O Gutkind; Marta E Mollerach; Juan A Ayala
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Novel genetic structure associated with an extended-spectrum beta-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria.

Authors:  Daniel Aubert; Thierry Naas; Marie-Frédérique Lartigue; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  Rapid genotyping of CTX-M extended-spectrum beta-lactamases by denaturing high-performance liquid chromatography.

Authors:  Li Xu; Jason Evans; Thomas Ling; Kathy Nye; Peter Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

Review 9.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

10.  Molecular Characterization of Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae from Wild Kelp Gulls in South America.

Authors:  Apostolos Liakopoulos; Björn Olsen; Yvon Geurts; Karin Artursson; Charlotte Berg; Dik J Mevius; Jonas Bonnedahl
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.